General Information of Drug Transporter (DT)
DT ID DTD0024 Transporter Info
Gene Name SLC22A6
Transporter Name Organic anion transporter 1
Gene ID
9356
UniProt ID
Q4U2R8
Post-Translational Modification of This DT
Overview ofSLC22A6 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Deubiquitination X-N-glycosylation X-Phosphorylation X-Ubiquitination X: Amino Acid

Deubiquitination

  Unclear Residue

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

Increasing SLC22A6 expression at the cell surface and an increased OAT1 transporter activity in cultured cells [1]

Role of PTM

Surface Expression Modulation

Related Enzyme

Ubiquitin carboxyl-terminal hydrolase 8 (USP8)

Experimental Material(s)

African green monkey kidney fibroblast-like (COS-7) cells

Experimental Method

Co-Immunoprecipitation

Detailed Description

Deubiquitination at SLC22A6 have been reported to increase its expression at the cell surface and transport activity in cultured cells.

N-glycosylation

  Asparagine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

Critically important for SLC22A6 to the plasma membrane [2], [3]

Role of PTM

Surface Expression Modulation

Modified Residue

Asparagine

Modified Location

113

Experimental Method

Co-Immunoprecipitation

Detailed Description

Glycosylation at SLC22A6 Asparagine 113 have been reported to be critically important for its transporter to the plasma membrane.

  PTM Phenomenon2

Have the potential to influence SLC22A6 [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

39

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC22A6 Asparagine 39 has the potential to affect its expression or activity.

  PTM Phenomenon3

Have the potential to influence SLC22A6 [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

56

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC22A6 Asparagine 56 has the potential to affect its expression or activity.

  PTM Phenomenon4

Have the potential to influence SLC22A6 [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

92

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC22A6 Asparagine 92 has the potential to affect its expression or activity.

  PTM Phenomenon5

Have the potential to influence SLC22A6 [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

97

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC22A6 Asparagine 97 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

Have the potential to influence SLC22A6 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

139

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A6 Serine 139 has the potential to affect its expression or activity.

  PTM Phenomenon2

Have the potential to influence SLC22A6 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

203

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A6 Serine 203 has the potential to affect its expression or activity.

  PTM Phenomenon3

Have the potential to influence SLC22A6 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

462

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A6 Serine 462 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

Have the potential to influence SLC22A6 [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

456

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A6 Threonine 456 has the potential to affect its expression or activity.

  PTM Phenomenon2

Have the potential to influence SLC22A6 [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

463

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A6 Threonine 463 has the potential to affect its expression or activity.

  Tyrosine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

Potentially affecting the transporter [6]

Role of PTM

On/Off Switch

Modified Residue

Tyrosine

Modified State

Tyrosine kinase inhibitors

Experimental Method

Co-Immunoprecipitation

Detailed Description

Removal of the Phosphorylation at SLC22A6 Tyrosine (i.e. Tyrosine kinase inhibitors) have been reported to have the potential to affect the transporter.

  PTM Phenomenon2

Have the potential to influence SLC22A6 [4]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

141

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A6 Tyrosine 141 has the potential to affect its expression or activity.

  PTM Phenomenon3

Have the potential to influence SLC22A6 [4]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

154

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A6 Tyrosine 154 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

Inhibiting the activity of SLC22A6 by reducing by its cell-surface expression [7]

Role of PTM

Trafficking to Plasma Membrane

Modified Residue

Lysine

Modified Location

48

Related Enzyme

Protein kinase C alpha type (PRKCA)

Experimental Material(s)

African green monkey kidney fibroblast-like (COS) cells

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC22A6 Lysine 48 have been reported to inhibit its transport activity.

  PTM Phenomenon2

Inhibiting the activity of SLC22A6 [8]

Role of PTM

Trafficking to Plasma Membrane

Modified Residue

Lysine

Modified Location

297

Related Enzyme

Protein kinase C alpha type (PRKCA)

Experimental Material(s)

African green monkey kidney fibroblast-like (COS-7) cells

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC22A6 Lysine 297 have been reported to inhibite its transport activity.

  PTM Phenomenon3

Inhibiting the activity of SLC22A6 [8]

Role of PTM

Trafficking to Plasma Membrane

Modified Residue

Lysine

Modified Location

303

Related Enzyme

Protein kinase C alpha type (PRKCA)

Experimental Material(s)

African green monkey kidney fibroblast-like (COS-7) cells

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC22A6 Lysine 303 have been reported to inhibite its transport activity.

  PTM Phenomenon4

Inhibiting the activity of SLC22A6 [8]

Role of PTM

Trafficking to Plasma Membrane

Modified Residue

Lysine

Modified Location

315

Related Enzyme

Protein kinase C alpha type (PRKCA)

Experimental Material(s)

African green monkey kidney fibroblast-like (COS-7) cells

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC22A6 Lysine 315 have been reported to inhibite its transport activity.

  Unclear Residue

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

Decreasing the expression and SLC22A6 activity [9]

Role of PTM

Degradation via Proteosome

Related Enzyme

E3 ubiquitin-protein ligase NEDD4 (NEDD4)
E3 ubiquitin-protein ligase NEDD4-like (NEDD4L)

Experimental Material(s)

African green monkey kidney fibroblast-like (COS-7) cells; Human Embryonic Kidney 293T (HEK-293T) cells

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC22A6 have been reported to decrease its expression and transport activity.
References
1 Regulation of organic anion transporters: Role in physiology, pathophysiology, and drug elimination. Pharmacol Ther. 2021 Jan;217:107647.
2 The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. Mol Pharmacol. 1999 Sep;56(3):570-80.
3 Role of glycosylation in the organic anion transporter OAT1. J Biol Chem. 2004 Apr 9;279(15):14961-6.
4 Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
5 Global Ion Suppression Limits the Potential of Mass Spectrometry Based Phosphoproteomics. J Proteome Res. 2019 Jan 4;18(1):493-507.
6 Post-translational modifications of transporters. Pharmacol Ther. 2018 Dec;192:88-99.
7 Lysine 48-linked polyubiquitination of organic anion transporter-1 is essential for its protein kinase C-regulated endocytosis. Mol Pharmacol. 2013 Jan;83(1):217-24.
8 Three ubiquitination sites of organic anion transporter-1 synergistically mediate protein kinase C-dependent endocytosis of the transporter. Mol Pharmacol. 2013 Jul;84(1):139-46.
9 Nedd4-2 but not Nedd4-1 is critical for protein kinase C-regulated ubiquitination, expression, and transport activity of human organic anion transporter 1. Am J Physiol Renal Physiol. 2016 May 1;310(9):F821-31.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.